Afrocentric InvestmentJSE:ACT -13.33%52 Cyclically Adjusted PS Ratio is 0.07 as of Jul. 07, 2026, which is 87% below its 10-year median of 0.53. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.08 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 359 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 96.38% on this metric.
The historical rank and industry rank for Afrocentric Investment's Cyclically Adjusted PS Ratio or its related term are showing as below:
JSE:ACT'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.06 Med: 0.53 Max: 1.28
Current: 0.08
During the past 13 years, Afrocentric Investment's highest Cyclically Adjusted PS Ratio was 1.28. The lowest was 0.06. And the median was 0.53.
JSE:ACT's Cyclically Adjusted PS Ratio is ranked better than 96.38% of 359
companies
in the Healthcare Providers & Services industry
Industry Median: 1.15
vs JSE:ACT: 0.08
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Afrocentric Investment's adjusted revenue per share data of for the fiscal year that ended in Dec25 was R8.564. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R11.78 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Afrocentric Investment (JSE:ACT) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Afrocentric Investment Cyclically Adjusted PS Ratio Related Terms
Afrocentric Investment Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment Cyclically Adjusted PS Ratio Chart
JSE:ACT vs HCA, THC, DVA: Cyclically Adjusted PS Ratio Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Cyclically Adjusted PS Ratio falls into.
Afrocentric Investment Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.07 mean?
Afrocentric Investment (JSE:ACT) has a Cyclically Adjusted PS Ratio of 0.07 as of Jul. 07, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Afrocentric Investment and its competitors. This is 87% below median its historical median of 0.53. Over the past decade, Afrocentric Investment's Cyclically Adjusted PS Ratio has ranged from 0.06 to 1.28. According to the industry distribution chart, Afrocentric Investment ranks #13 out of 359 companies in the Healthcare Providers & Services industry, placing it in the top 3.6%.
Is Afrocentric Investment's Cyclically Adjusted PS Ratio too high?
Afrocentric Investment's current Cyclically Adjusted PS Ratio of 0.07 is 87% below median its 10-year median of 0.53. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 1.28. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.15. Afrocentric Investment's value of 0.07 is 93.9% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #13 out of 359 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Cyclically Adjusted PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #13 out of 359 companies for Cyclically Adjusted PS Ratio. This places Afrocentric Investment in the top 4% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PS Ratio is 1.15. Afrocentric Investment's value of 0.07 is 93.9% below this benchmark. Historically, Afrocentric Investment's own Cyclically Adjusted PS Ratio has ranged from 0.06 to 1.28 over the past decade. While the company's 10-year median is 0.53 vs. the industry median of 1.15, Afrocentric Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.15, based on 359 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current Cyclically Adjusted PS Ratio of 0.07 is 93.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Cyclically Adjusted PS Ratio is 0.07, which is 87% below median its own 10-year median of 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.08, compared to a current price of R0.78 — trading 62.5% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.07, which is 87% below median its 10-year median of 0.53 and 93.9% below the Healthcare Providers & Services industry median of 1.15. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Cyclically Adjusted PS Ratio is 0.07 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.78 is trading 62.5% below its estimated GF Value™ of R2.08.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Cyclically Adjusted PS Ratio: 0.07 (87% below median its 10-year median of 0.53)
GF Value™: R2.08 vs. price of R0.78 (62.5% below fair value)
Industry Position: 93.9% below the Healthcare Providers & Services median (#13 of 359)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
